What is the recommended treatment for ureteral stones according to their size range?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment for Ureteric Stones by Size Range

For ureteral stones, treatment selection depends critically on stone size and location: stones <5mm can be observed with medical expulsive therapy (MET), stones 5-10mm should be treated with ureteroscopy (URS) or shock wave lithotripsy (SWL) with URS preferred for distal stones, stones 10-20mm require URS as first-line treatment, and stones >20mm necessitate percutaneous antegrade approach. 1, 2

Stones <5mm: Conservative Management

Observation with MET is the appropriate initial approach for stones under 5mm, as spontaneous passage occurs in approximately 75% of cases 1. The passage rate varies by location:

  • Distal ureter: 89% for stones <5mm
  • Upper ureter: 75% for stones <5mm
  • Mid ureter: 58-70%

Stone passage typically occurs within 17 days (range 6-29 days) 1. MET should be discontinued if complications develop including infection, refractory pain, or declining renal function 1.

Stones 5-10mm: Surgical Intervention Required

Distal Ureteral Stones ≤10mm

Both URS and SWL are acceptable options, but URS demonstrates superior stone-free rates 2. Contemporary evidence shows URS achieves higher single-procedure success rates compared to SWL for distal stones 2, 3.

Key decision factors:

  • URS provides higher stone-free rates but requires anesthesia and possible stenting
  • SWL is less invasive but has lower success rates and higher retreatment rates
  • Retreatment rates are significantly lower with URS (p<0.01) 3

Proximal Ureteral Stones <20mm

For stones <10mm, either URS or SWL may be offered 2. However, meta-analysis demonstrates URS achieves higher stone-free rates in a single procedure compared to SWL for proximal stones 2.

For stones 10-20mm in the proximal ureter, URS should be the preferred first-line treatment 2, 4. The evidence shows:

  • URS effectiveness is superior to SWL for stones >10mm 5, 4
  • Stone-free rates are significantly higher with URS (p<0.01, OR=0.40) 3
  • Retreatment rates are substantially lower with URS 3

Important Caveat for SWL

If SWL is chosen, initiate treatment with low-energy shockwaves and gradually escalate to reduce bleeding complications 2. If no stone fragmentation or clearance occurs after initial SWL, switch to URS 2. After 2 unsuccessful SWL sessions, an alternate modality (URS) must be undertaken 2.

Stones >20mm: Percutaneous Approach

For ureteral stones >20mm, or stones that have failed retrograde URS or SWL, offer a percutaneous antegrade approach 2. These larger stones are not amenable to standard endoscopic techniques and require more invasive intervention.

Critical Pitfalls to Avoid

  1. Do not routinely place stents with SWL - both fragmentation and stone-free rates are notably lower with routine stenting 4

  2. Do not persist with failed SWL - if obstruction continues after initial treatment, switch modalities promptly to prevent irreversible renal function loss 2

  3. Do not use stone diameter alone for 10-20mm stones - stone volume >1064mm³ predicts worse RIRS outcomes; consider mini-PCNL for larger volumes 6

  4. Avoid blind basket extraction without fluoroscopic control and guidewires 7

Quality of Life Considerations

URS provides better health-related quality of life than SWL for ureteral stones, while the opposite is true for renal stones 8. MET provides better quality of life than active surveillance alone 8.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.